Physician

Michael Kai-Jia Lam, M.D.

According to 2025 Medicare claims, Michael Lam, M.D. (NPI: 1548200835) practices ophthalmology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Fort Bend, TX. This provider's primary affiliated billing organization is HOUSTON RETINA ASSOCIATES PA (NPI: 1942347570; TIN: 010699322) and primary practice location at 77479-2649.

Lam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 581 traditional Medicare patients, billed 50,275 HCPCS/CPT codes, and received $2,433,965 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 925 prescription claims across 308 beneficiaries totaling $443,978 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 28 records totaling $1,200. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $654,502 to $2,433,965. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $65,781 to $443,978. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $654,502 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $883,414 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $771,338 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $904,953 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,185,645 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,378,897 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,582,298 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,762,956 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,251,929 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,433,965 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155347,943$654,502
20165879,274$883,414
20176139,211$771,338
20186109,048$904,953
20196199,034$1,185,645
20205047,282$1,378,897
20214927,574$1,582,298
202254512,172$1,762,956
202356142,154$2,251,929
202458150,275$2,433,965

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$267K$535K2015 Drug cost: $65,781 (USD; Tot_Drug_Cst)2016 Drug cost: $136,668 (USD; Tot_Drug_Cst)2017 Drug cost: $129,142 (USD; Tot_Drug_Cst)2018 Drug cost: $164,742 (USD; Tot_Drug_Cst)2019 Drug cost: $69,219 (USD; Tot_Drug_Cst)2020 Drug cost: $176,134 (USD; Tot_Drug_Cst)2021 Drug cost: $355,373 (USD; Tot_Drug_Cst)2022 Drug cost: $494,317 (USD; Tot_Drug_Cst)2023 Drug cost: $534,673 (USD; Tot_Drug_Cst)2024 Drug cost: $443,978 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015153577$65,781
2016169722$136,668
2017199702$129,142
20182431,026$164,742
2019238922$69,219
2020220865$176,134
20213091,121$355,373
20223741,188$494,317
20234021,170$534,673
2024308925$443,978

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2251,008$109
92014Established patient complete exam of visual system4891,215$94
92012Established patient problem focused exam of visual system241294$70
92134Imaging of retina5421,546$31
92202Extended exam of the back part of the eye with optic nerve drawing371742$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept1384,081$385,314
Prednisolone AcetatePrednisolone Acetate1314,787$4,769
Atropine SulfateAtropine Sulfate802,998$2,910
Bromfenac SodiumBromfenac Sodium27664$2,910
LatanoprostLatanoprost925,884$1,567

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$1,200Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Kai-Jia Lam, M.D.?

Tedicare shows public-source Medicare data for Michael Kai-Jia Lam, M.D. (NPI 1548200835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Kai-Jia Lam, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Kai-Jia Lam, M.D.?

Michael Kai-Jia Lam, M.D. is linked to HOUSTON RETINA ASSOCIATES PA (billing NPI 1942347570) in the available physician profile data.

Does Michael Kai-Jia Lam, M.D. have Open Payments data?

Michael Kai-Jia Lam, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.